etiee INSTITUTION: ATTENTION: CAP NUMBER: KIT INFORMATION: COPIED TO: LKF Laboratorium fur Klinische Forschung GmbH Schwentinental GE 24223 Volker El-Samalouti PhD 7234136-01 Kit# 1 Kit ID: Kit Mailed: Original Evaluation: 29874352 5/8/2017 6/13/2017 CAP Next Mailing Date: 9/25/2017 LEGEND: Exception Reason Codes appearing in this evaluation: = Educational challenge. Reviewed By.7 7 7 q,a;e Fc ) The College of American Pathologists recomrnends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory. 0001 4072 Page 1 of 9
Specimen FH9-B 2017 Hernatology Auto Differentials, FH9 - No. of Limits of Acceptability your Result Mean S.D. Labs S.D.I Lower Upper Grade Plot of the Relative Distance of Results from MCV FH9-06 74.7 75.83 0.84 199-1.3 73.3 78.4 Acceptable --,,,,- fl, FH9-07 84.3 85.98 0.97 200-1.7 83.0 88.9 Acceptable FH9-B 2017 SYSMEX XE-2100,2100D/L FH9-08 81.5 83.30 0.98 199-1.8 80.3 86.3 Acceptable I FH9-09 81.1 82.80 0.89 198-1.9 80.1 85.5 Acceptable FH9-10 87.9 89.75 1.00 199-1.9 86.7 92.8 Acceptable X: Result is outside the acceptable limits MCH FH9-06 25.3 25.45 0.34 199-0.4 24.4 26.5 Acceptable Pg FH9-07 29.7 30.32 0.36 199-1.7 29.2 31.5 Acceptable FH9-B 2017 SYSMEX XE-2100,2100D /L FH9-08 29.0 29.42 0.38 200-1.1 28.2 30.6 Acceptable FH9-09 28.5 28.59 0.35 198-0.3 27.5 29.7 Acceptable FH9-10 31.3 31.95 0.40 197-1.6 30.7 33.2 Acceptable MCHC FH9-06 33.9 33.60 0.55 199 +0.5 31.9 35.3 Acceptable g/dl FH9-07 35.2 35.26 0.51 198-0.1 33.7 36.9 Acceptable FH9-B 2017 SYSMEX XE-2100,2100D/L FH9-08 35.6 35.31 0.51 198 +0.6 33.7 36.9 Acceptable FH9-09 35.2 34.53 0.52 198 +1.3 32.9 36.1 Acceptable._._. FH9-10 35.6 35.59 0.49 197 0.0 34.1 37.1 Acceptable - Platelet Count FH9-06 56 57.9 3.0 199-0.6 43 73 Acceptable x 10E9/L FH9-07 135 130.2 6.4 199 +0.8 97 163 Acceptable FH9-B 2017 'M=. SYSMEX XE-2100,2100D/L FH9-08 126 129.4 6.1 199-0.6 97 162 Acceptable FH9-09 229 228.4 7.3 198 +0.1 171 286 Acceptable.e.., FH9-10 531 515.5 18.9 198 +0.8 386 645 Acceptable -. The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory. 0001 4074 Page 3 of 9
I _ No. of Limits of Acceptability Specimen Result Mean S.D. Labs S.D.I Lower Upper Grade Plot of the Relative Distance of Results from Lymphs FH9-06 35.4 37.38 1.48 195-1.3 32.9 41.9 Acceptable % FH9-07 33.1 32.24 1.18 197 +0.7 28.6 35.8 Acceptable FH9-B 2017, SYSMEX XE-2100,2100D/L FH9-08 32.1 32.28 1.13 195-0.2 28.9 35.7 Acceptable FH9-09 32.6 32.22 0.97 196 +0.4 29.3 35.2 Acceptable...,,, FH9-10 24.8 26.37 0.74 195-2.1 24.1 28.6 Acceptable Lymphs Absolute FH9-06 1.09 1.119 0.055 188-0.5 0.11 2.12 Acceptable x 10E9/L FH9-07 0.97 0.973 0.051 191-0.1 0.00 1.98 Acceptable FH9-B 2017,...L..., SYSMEX XE-2100,2100D/L FH9-08 0.93 1.004 0.047 190-1.6 0.00 2.01 Acceptable -1---.- I - - FH9-09 2.20 2.155 0.088 188 +0.5 1.15 3.16 Acceptable I FH9-10 4.59 4.828 0.170 189-1.4 3.82 5.83 Acceptable Monocytes FH9-06 13.60 10.474 1.154 194 +2.7 7.01 13.94 Acceptable `)/0 FH9-07 9.60 9.280 0.828 195 +0.4 6.79 11.77 Acceptable FH9-B 2017 SYSMEX XE-2100,2100D/L FH9-08 9.70 9.296 0.850 195 +0.5 6.74 11.85 Acceptable FH9-09 8.70 9.642 0.634 194-1.5 7.74 11.55 Acceptable FH9-10 10.70 9.840 0.559 192 +1.5 8.16 11.52 Acceptable Monocytes Absolute FH9-06 0.42 0.312 0.038 188 +2.9 0.00 1.32 Acceptable. x 10E9/L FH9-07 0.28 0.280 0.025 187 0.0 0.00 1.28 Acceptable FH9-B 2017 '. SYSMEX XE-2100,2100D/L FH9-08 0.28 0.287 0.026 186 M.3 0.00 1.29 Acceptable.. FH9-09 0.59 0.642 0.047 187-1.1 0.00 1.65 Acceptable FH9-10 1.98 1.795 0.114 188 +1.6 0.79 2.80 Acceptable The College of American Pathologists recomrnends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory. 0001 4076 Page 5 of 9
I.* 00. 4.1111, 0. **041.4,45, eige4,11.1,0** Specimen Result Mean S.D. No. of Labs Limits of Acceptability S.D.I Lower Upper IG FH9-06 10.1 10.12 0.50 144 0.0 % FH9-07 10.6 11.45 0.53 144-1.6 SYSMEX XE-2100,2100D/L FH9-08 10.7 11.40 0.51 144-1.4 FH9-09 11.1 11.44 0.42 144-0.8 FH9-10 12.4 12.46 0.49 143-0.1 yo ur Grade Plot of the Relative Distance of Results from IG Absolute FH9-06 0.31 0.302 0.017 142 +0.5 x 10E9/L FH9-07 0.31 0.345 0.022 144-1.6 SYSMEX XE-2100,2100D/L FH9-08 0.31 0.354 0.021 143-2.1 FH9-09 0.75 0.765 0.038 143-0.4 FH9-10 2.29 2.284 0.106 142 +0.1 nrbc% FH9-06 5.6 4.85 0.49 89 +1.5 FH9-07 0.0 0.00 0.00 89 0.0 SYSMEX XE-2100,2100D/L FH9-08 0.0 0.00 0.00 90 0.0 echeck XE CONTROL FH9-09 7.3 6.70 0.42 88 +1.4 FH9-10 5.8 5.80 0.33 89 0.0 nrbc Absolute FH9-06 0.16 0.138 0.016 86 +1.4 x 10E3/uL FH9-07 0.00 0.000 0.000 87 0.0 SYSMEX XE-2100,2100D/L FH9-08 0.00 0.000 0.000 87 0.0 echeck XE CONTROL FH9-09 0.46 0.423 0.028 86 +1.3 FH9-10 1.01 1.002 0.057 86 +0.1 Method Specimen Result Good Response Acceptable Response Grade Blood Cell ID BCP-11 OVALOCYTE OVALOCYTE Good BCP-12 LYMPHOCYTE LYMPHOCYTE Good BCP-13 MONOCYTE MONOCYTE Good The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory. 0001 4078 Page 7 of 9
im* e..feeefb* tem* e fbio e.06 et fbe CAP CAP #: 7234136 Subspecialty : Hematology Proficiency Event Proficiency Event Proficiency Event 2016 3 2017 1 2017 2 Current Event Performance Cumulative CLIA '88 Performance Regulated Analyte Event Score A Event Score % Event Score % Interpretation Interpretation Cell ID/Flow Differential FH9-C 5/5 100 FH9-A 5/5 100 FH9-B 5/5 100 Satisfactory Successful Erythrocyte Count (RBC) H-19-C 5/5 100 FF19-A 5/5 100 F1-19-B 5/5 100 Satisfactory Successful Hematocrit FH9-C 5 / 5 100 FH9-A 5/5 100 FH9-B 5/5 100 Satisfactory Successful Hemoglobin FH9-C 5/5 100 FH9-A 5/5 100 FH9-B 5/5 100 Satisfactory Successful Leukocyte Count (WBC) 1+19-C 5/5 100 FH9-A 5/5 100 FH9-B 5/5 100 Satisfactory Successful Platelet Count FH9-C 5/5 100 FH9-A 5/5 100 FH9-B 5/5 100 Satisfactory Successful Fibrinogen CGL-C 5/5 100 CGL-A 5/5 100 Pending Successful <4> PTT CGL-C 5/5 100 CGL-A 5/5 100 Pending Successful <4> Prothrombin Time CGL-C 5 / 5 100 CGL-A 5/5 100 Pending Successful <4> Hematology 45/45 100 45/45 100 30/30 100 Satisfactory Successful <4> Scorecard performance pending future evaluation or may not be applicable due to discontinued testing or use of a waived method. The College of American Pathologists recomrnends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of ani, individual clinical laboratoit. 0001 4080 Page 9 of 9
444, Method Specimen Result Good Response Acceptable Response Grade BCP-14 PLATELET, NORMAL PLATELET, NORMAL Good BCP-15 BASOPHIL, ANY STAGE BASOPHIL, ANY STAGE Good Blood Cell ID Ungraded BCP-16 LYMPHOCYTE BCP-17 POLYCHROMATOPHILIC RBC BCP-18 MONOCYTE BCP-19 NEUTROPHIL, SEG/BAND BCP-20 SPHEROCYTE The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory. 0001 79 Page 8
Specimen City / State: Schwendnental GE 24223 No. of Limits of Acceptability your Resuh Mean S.D. Labs S.D.I Lower Upper Grade Eosinophils FH9-06 9.1 9.23 0.75 197-0.2 6.9 11.5 Acceptable A) FH9-07 10.2 10.35 0.81 198-0.2 7.9 12.8 Acceptable FH9-B 2017 SYSMEX XE-2100,2100D/L FH9-08 11.4 10.36 0.90 198 +1.2 7.6 13.1 Acceptable FH9-09 9.8 10.15 0.88 196-0.4 7.4 12.9 Acceptable FH9-10 10.0 11.18 0.87 195-1.4 8.5 13.8 Acceptable -100 Plot of the Relative Distance of Results from 4. _ ' -80-60 -40-20 0 20 40 60 80 100 _ Eosinophils Absolute FH9-06 0.28 0.276 0.024 189 +0.2 0.00 1.28 Acceptable x 10E9/L FH9-07 0.30 0.312 0.026 191-0.5 0.00 1.32 Acceptable FH9-B 2017 SYSMEX XE-2100,2100D/L FH9-08 0.33 0.322 0.032 190 +0.2 0.00 1.33 Acceptable FH9-09 0.66 0.678 0.063 190-0.3 0.00 1.68 Acceptable FH9-10 1.84 2.045 0.166 189-1.2 1.04 3.05 Acceptable Basophils FH9-06 57.5 60.78 1.39 197-2.4 56.6 65.0 Acceptable w A) FH9-07 67.6 68.25 1.40 198-0.5 64.0 72.5 Acceptable FH9-B 2017 SYSMEX XE-2100,2100D /L FH9-08 67.2 68.26 1.23 197 M.9 64.5 72.0 Acceptable FH9-09 64.1 65.44 0.94 197-1.4 62.6 68.3 Acceptable FH9-10 71.5 71.86 0.78 198-0.5 69.5 74.3 Acceptable Basophils Absolute FH9-06 1.77 1.819 0.070 191-0.7 0.81 2.82 Acceptable x 10E9/L FH9-07 1.98 2.058 0.074 189-1.1 1.05 3.06 Acceptable FH9-B 2017 1, SYSMEX XE-2100,2100D/L FH9-08 1.95 2.119 4 0.077 191-2.2.., t 1.11 3.12 Acceptable ' FH9-09 4.33 4.378 0.146 191 1-0.3 3.37 5.38 Acceptable FH9-10 13.22 13.154 0.295 190 +0.2 12.15 14.16 Acceptable The College of American Pathologists recornmends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory. 0001 7 Page 6
Specimen Result Mean S.D. No. o f Limits of Acceptability Labs S.D.I Lower Upper Grade Plot of the Relative Distance of Results from MPV FH9-06 9.5 9.60 0.29 175-0.3 8.7 10.5 Acceptable fl FH9-07 9.9 10.11 0.22 174-0.9 9.4 10.8 Acceptable FH9-B 2017 SYSMEX XE-2100,2100D/L FH9-08 10.0 10.17 0.25 175-0.7 9.4 11.0 Acceptable FH9-09 9.8 9.82 0.18 177-0.1 9.2 10.4 Acceptable FH9-10 10.0 9.98 0.16 177 +0.1 9.5 10.5 Acceptable RDW FH9-06 43.7 44.04 0.71 50-0.5 41.9 46.2 Acceptable FH9-07 41.4 41.43 0.54 49 0.0 39.8 43.1 Acceptable FH9-B 2017. SYSMEX XE-2100,2100D/L FH9-08 ' 41.3 42.33 0.63 50-1.6 40.4 44.3 Acceptable._. fl FH9-09 43.7 44.48 0.72 50-1.1 42.3 46.7 Acceptable FH9-10 44.8 44.96 0.45 50-0.3 43.6 46.4 Acceptable Neut/Gran 'FH9-06 41.9 42.93 1.32 197-0.8 38.9 47.0 Acceptable % FH9-07 47.1 48.13 1.27 196-0.8 44.3 52.0 Acceptable FH9-B 2017 SYSMEX XE-2100,2100D /L FH9-08 46.8 48.06 1.17 196-1.1 44.5 51.6 Acceptable FH9-09 48.9 48.00 1.03 196 +0.9 44.8 51.2 Acceptable FH9-10 54.5 52.64 1.01 196 +1.8 49.6 55.7 Acceptable -100-80 -60-40 -20 0 20 40 60 80 100 Neut/Gran Absolute FH9-06 1.29 1.285 0.063 190 +0.1 0.28 2.29 Acceptable x 10E9/L FH9-07 1.38 1.451 0.059 188-1.2 0.45 2.46 Acceptable FH9-B 2017 I SYSMEX XE-2100,2100D/L FH9-08 1.36 1.494 0.060 189-2.2 0.49 2.50 Acceptable., F1-19-C2016 FH9-09 3.31 3.215 0.122 188 +0.8 2.21 4.22 Acceptable., E.: FH9-10 10.08 9.637 0.287 189 +1.5 8.63 10.64 Acceptable The College of Arnerican Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any individual clinical laboratory. 0001 75 Page 4
325 Waukegan Road, NorthfieEd, Illinois 60093-2750 800-323-4040 - cap.org Specimen No. of Limits of Acceptability your Result Mean S.D. Labs S.D.I Lower Upper Grade Plot of the Relative Distance of Results from White Blood Cell Count FH9-06 3.1 2.99 0.10 203 +1.0 2.5 3.5 Acceptable x 10E9/L FH9-07 2.9 3.02 0.10 204-1.2 2.5 3.5 Acceptable FH9-B 2017 SYSMEX XE-2100,2100D/L FH9-08 2.9 3.11 0.10 t 204-2.1 2.6 3.6 Acceptable FH9-09 6.8 6.70 0.21 204 +0.5 5.6 7.8 Acceptable FH9-10 18.5 18.31 0.39 203 +0.5 15.5 21.1 Acceptable Red Blood Cell Count FH9-06 2.41 2.416 0.033 201-0.2 2.27 2.57 Acceptable x 10E12/L FH9-07 5.42 5.317 0.076 202 +1.4 4.99 5.64 Acceptable FH9-B 2017 SYSMEX XE-2100,2100D/L FH9-08 6.48 6.383 0.091 202 +1.1 5.99 6.77 Acceptable FH9-09 4.49 4.453 0.060 202 +0.6 4.18 4.72 Acceptable FH9-10 5.46 5.363 0.076 203 +1.3 5.04 5.69 Acceptable _ I t Hemoglobin FH9-06 6.1 6.16 0.08 205-0.7 5.7 6.6 Acceptable g/dl FH9-07 16.1 16.12 0.18 205-0.1 14.9 17.3 Acceptable FH9-B 2017 I I SYSMEX XE-2100,2100D/L FH9-08 18.8 18.78 0.21 203 +0.1 17.4 20.1 Acceptable I i FH9-09 12.8 12.74 0.14 202 +0.5 11.8 13.7 Acceptable FH9-10 17.1 17.14 0.20 203-0.2 15.9 18.4 Acceptable Hematocrit FH9-06 18.00 18.291 0.476 206-0.6 17.19 19.39 Acceptable % FH9-07 45.70 45.764 0.706 203-0.1 43.01 48.51 Acceptable FH9-B 2017 SYSMEX XE-2100,2100D/L FH9-08 52.80 53 223 0.819 202 M.5 50.02 56.42 Acceptable FH9-09 36.40 36.941 0.561 202-1.0 34.72 39.16 FH9-10 48.00 48.201 0.745 204-0.3 45.30 51.10 Acceptable Acceptable The College of American Pathologists recommends that the result of this interlaboratory comparison not be used as a sole criterion for judging the performance of any indiyidual clinical laboratory. 0001 73 Page 2